Facilities White Papers & Case Studies

  1. Flatiron Prospective Evidence Generation 9/25/2024

    Explore prospective evidence generation and pragmatic approaches that can help you address staffing challenges and the issue of complexity that is driving up the failure rate of clinical studies.

  2. FSP And IVD Clinical Trials 6/3/2024

    This study highlights the benefits of ProPharma's FSP services for clinical trials, including scalability, risk reduction, cost savings, and timely delivery.

  3. Unlocking Endurance With MEMS Technology: Extending Relay Lifespan By 1000x 6/12/2024

    Explore how innovative Ideal Switch technology is setting new benchmarks for reliability and efficiency in semiconductor testing.

  4. Innovative Multilayer Extrusion Technology Solves Product Redesign Challenges 8/20/2024

    A multinational medical device company successfully worked to redesign a component used in cardiovascular surgery.

  5. Optimizing Upstream Process Development To Increase mAb Titers 3/28/2025

    Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.

  6. A Translational Mouse Model For Non-Genetic Heterotopic Ossification 3/28/2025

    Reproducing the thermal lesion/tenotomy-induced mouse model can help overcome the challenge of unpredictable heterotopic ossification localization and enable the development of targeted interventions.

  7. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

    Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

  8. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

    Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

  9. Robust, Scalable Strategy For Monodisperse Nanosuspensions Of Poorly Soluble Drugs 5/16/2025

    By tailoring the formulation strategy, selecting the appropriate excipients, and fine-tuning process conditions, see how our team was able to improve bioavailability and in vivo exposure.

  10. Organizational Assessment For A Large MedTech Company 6/5/2025

    Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.